Avanos Medical, Inc. (NYSE:AVNS) Sees Large Decline in Short Interest

Avanos Medical, Inc. (NYSE:AVNS) saw a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 632,000 shares, a drop of 5.2% from the January 15th total of 666,900 shares. Currently, 1.4% of the company’s shares are short sold. Based on an average daily volume of 444,200 shares, the days-to-cover ratio is presently 1.4 days.

Hedge Funds Weigh In On Avanos Medical

Several hedge funds and other institutional investors have recently made changes to their positions in AVNS. Illinois Municipal Retirement Fund increased its holdings in Avanos Medical by 3.1% in the 4th quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company’s stock valued at $402,000 after purchasing an additional 748 shares in the last quarter. Comerica Bank boosted its position in shares of Avanos Medical by 3.4% in the fourth quarter. Comerica Bank now owns 22,903 shares of the company’s stock worth $365,000 after buying an additional 755 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Avanos Medical by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company’s stock valued at $411,000 after buying an additional 901 shares in the last quarter. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its holdings in shares of Avanos Medical by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock valued at $161,000 after buying an additional 1,289 shares during the period. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Trading Up 0.9 %

Shares of AVNS stock opened at $15.67 on Thursday. Avanos Medical has a fifty-two week low of $14.98 and a fifty-two week high of $25.36. The firm’s 50 day moving average price is $16.33 and its two-hundred day moving average price is $19.96. The stock has a market cap of $719.96 million, a price-to-earnings ratio of 46.07 and a beta of 0.98. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.